Grigoriadis Dimitri E.

Track

Insider profile

Grigoriadis Dimitri E.'s trades of Neurocrine Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-02-07 2018-02-05
PlS Planned sale
15,385 +43.9%
290.69
US$3,602,157 		15,385 +43.9% 290.69 US$3,602,157
2018-02-07 2018-02-05
PlS Planned sale
84,793 -6.2%
289.75
US$462,181 		84,793 -6.2% 289.75 US$462,181
2018-01-18 2018-01-16
PlS Planned sale
55,658 +37.8%
339.24
US$500,453 		55,658 +37.8% 339.24 US$500,453
2017-04-13 2017-04-12
PlS Planned sale
204 -0.2%
51.23
US$10,451 		204 -0.2% 51.23 US$10,451
2017-04-13 2017-04-12
PlS Planned sale
12,861 -9.1%
50.41
US$648,323 		12,861 -9.1% 50.41 US$648,323
2017-02-08 2017-02-06
PlS Planned sale
727 -0.6%
43.13
US$31,356 		727 -0.6% 43.13 US$31,356
2017-02-06 2017-02-03
PlS Planned sale
1,375 -1.2%
42.56
US$58,520 		1,375 -1.2% 42.56 US$58,520
2017-01-18 2017-01-17
PlS Planned sale
1,625 -1.4%
40.63
US$66,024 		1,625 -1.4% 40.63 US$66,024
2017-01-12 2017-01-10
PlS Planned sale
1,625 -1.4%
43.39
US$70,509 		1,625 -1.4% 43.39 US$70,509
2016-02-04 2016-02-03
PlS Planned sale
1,375 -1.2%
37.98
US$52,222 		1,375 -1.2% 37.98 US$52,222
2016-01-21 2016-01-19
PlS Planned sale
1,625 -1.5%
46.76
US$75,985 		1,625 -1.5% 46.76 US$75,985
2016-01-13 2016-01-11
PlS Planned sale
1,625 -1.5%
44.21
US$71,841 		1,625 -1.5% 44.21 US$71,841